June 11, 2020 / 12:47 PM / a month ago

BRIEF-BioVie Says Received Guidance From FDA On Next Clinical Trial Design For BIV201

June 11 (Reuters) - Biovie Inc:

* BIOVIE INC - RECEIVED GUIDANCE FROM FDA ON NEXT CLINICAL TRIAL DESIGN FOR BIV201 IN PATIENTS WITH REFRACTORY ASCITES DUE TO LIVER CIRRHOSIS

* BIOVIE INC - PLANS TO COMMENCE A RANDOMIZED 24-PATIENT PHASE 2 STUDY THIS YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below